Dr. Ian Ganly, a graduate of the University of Glasgow Medical School, has established himself as a leading Surgical Oncologist at Memorial Sloan Kettering Cancer Center. His residency at the Royal Infirmary of Edinburgh laid a strong foundation for his expertise in head and neck oncology. Dr. Ganly’s commitment to excellence is reflected in his numerous awards and his active involvement in academic and professional societies, where he continues to mentor the next generation of oncologists.
Education
- Medical School: University of Glasgow Medical School, Scotland
- Residency: Royal Infirmary of Edinburgh
- Board Certification: American Board of Otolaryngology
Awards
- Honor Award – American Academy of Otolaryngology
- Distinguished Service Award – American Head and Neck Society
- Clinical Excellence Award – MSKCC
Professional Memberships and Affiliation
- American Head and Neck Society
- American Thyroid Association
- Royal College of Surgeons of Edinburgh
Clinical Experience
With over 20 years in the field, Dr. Ian Ganly is a distinguished Surgical Oncologist at MSKCC, specializing in advanced surgical techniques for differentiated and anaplastic thyroid and head and neck cancers. He has a proven track record in handling complex thyroidectomies and head and neck surgeries, including those involving critical structures in the neck. Dr. Ganly is also instrumental in implementing minimally invasive procedures that reduce recovery time and improve patient outcomes.
Research and Publications
- “Survival Differences in Thyroid Cancer”
- “Anaplastic Thyroid Cancer: Treatment Modalities”
- “Minimally Invasive Techniques in Thyroid Surgery”
Dr. Ian Ganly, a graduate of the University of Glasgow Medical School, has established himself as a leading Surgical Oncologist at Memorial Sloan Kettering Cancer Center. His residency at the Royal Infirmary of Edinburgh laid a strong foundation for his expertise in head and neck oncology. Dr. Ganly’s commitment to excellence is reflected in his numerous awards and his active involvement in academic and professional societies, where he continues to mentor the next generation of oncologists.